Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...

Three studies attempting to tease out the potential effects of glucagon-like peptide 1 receptor agonists (GLP-1 RA) taken before or during pregnancy were presented at the annual meeting of the ...

GLP-1 drugs, originally for type 2 diabetes, are increasingly used for weight loss, but they can worsen eating disorders. Rapid weight loss from these drugs can reinforce harmful eating behaviors ...

The two organizations filed a similar lawsuit against the agency in October after it removed Eli Lilly's tirzepatide, another GLP-1, from its shortage list. In the suit, the association and the ...

A large-scale study analyzing data from over 60 million patients finds no evidence that GLP-1 receptor agonists increase suicidality risk in type 2 diabetes patients, challenging previous safety ...

Amgen isn't a big player in the GLP-1 drug market, but that could change in the not-too-distant future. MariTide only needs to be taken once a month, and it's helped people lose up to 20% of their ...

In the final weeks of his administration, President Biden’s Food and Drug Administration quietly ended the “shortage” of tirzepatide, a popular GLP-1 medication. That means on March 19 ...

“GLP-1 medications have made a transformative impact in the obesity care space,” said Joseph Nadglowski, President and CEO of the OAC. “As these medicines continue to grow in ...

Millions of Americans have tried GLP-1 medications like Ozempic, Mounjaro and Wegovy, polls show, but pharmacy claims data show that many people stop taking them within less than one year.

“Yes, I am on a GLP-1, or a weight loss medication." "Now, if you have been following me for a long time, you’ll know that I’ve gained and lost weight several times very publicly," they ...

A whopping one in eight adults in the US have tried GLP-1 medications like Ozempic and Wegovy, but despite their massive popularity, many people taking the drug do so in secret. Certainly there ...